Skip to main content
. 2022 May 10;15:57. doi: 10.1186/s13048-022-00984-4

Fig. 1.

Fig. 1

Fisetin inhibited the proliferation of both human ovary carcinoma cell lines (A2780 and OVCAR-3) in a dose-dependent manner. (A) The chemical structure of fisetin. (B) The MTT assay indicated that fisetin reduced the proliferation of both OC cell lines after treatment at incremental concentrations (25, 50 and 100 mmol/L) for 72 h. (C) Quantification of vital cells after fisetin treatment